Edap Tms S.A. (FOCL)
Nasdaq: FOCL · Electromedical & Electrotherapeutic Apparatus · 69120 Vaulx En Velin, FR · filing with the SEC since 1998
Income statement, as filed
In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 |
| Report filed | Mar 25, 2026 | Mar 27, 2025 | Mar 28, 2024 |
| Revenue | 70,527,000 | 69,395,000 | · |
| Cost of revenue | 40,526,000 | 40,652,000 | · |
| Gross profit | 30,001,000 | 28,744,000 | · |
| Research and development | 9,661,000 | 8,363,000 | · |
| Sales and marketing | 27,315,000 | 27,363,000 | · |
| General and administrative | 17,720,000 | 15,243,000 | · |
| Total operating expenses | 54,695,000 | 50,969,000 | · |
| Operating income | -24,694,000 | -22,225,000 | · |
| Interest expense | 789,000 | 256,000 | · |
| Interest and investment income | 252,000 | 861,000 | · |
| Interest income (expense), net | -3,110,000 | 606,000 | · |
| Income before income taxes | -28,808,000 | -20,271,000 | · |
| Income tax expense | 438,000 | 313,000 | · |
| Net income including non-controlling interests | -29,246,000 | -20,584,000 | · |
| Net income | -29,246,182 | -20,584,271 | · |
| Earnings per share, basic | -0.78 | -0.55 | · |
| Earnings per share, diluted | -0.78 | -0.55 | · |
| Weighted average shares, basic | 37,442,155 | 37,286,446 | 36,996,722 |
| Weighted average shares, diluted | 37,442,155 | 37,286,446 | 36,996,722 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSales and marketing the cost of finding and serving customers
us-gaap:SellingAndMarketingExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperatingInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding